毒性药材专题知识库构建及应用

doi:10.19803/j.1672-8629.20240705

中国药物警戒 ›› 2024, Vol. 21 ›› Issue (12): 1415-1418.
DOI: 10.19803/j.1672-8629.20240705

毒性药材专题知识库构建及应用

李小阳¹, 王贻琳², 许静², 佟琳¹, 翟敏³, 蒋文博³, 何燕贤³, 雷蕾^1#, 游云^2,*

¹中国中医科学院中医药信息研究所,北京 100700;
²中国中医科学院中药研究所,100700;
³北斗天下卫星导航有限公司,北京 100160

收稿日期:2024-09-11 出版日期:2024-12-15 发布日期:2024-12-16
通讯作者: ^*游云,女,博士,研究员,中药药理学。E-mail: yyou@icmm.ac.cn,^#为共同通信作者。
作者简介:李小阳,女,硕士,助理研究员,中医药信息学。
基金资助:
中国中医科学院科技创新工程（毒性药材专题知识库构建及应用CI2021A03709）; 国家自然科学基金资助项目（82274244）

Construction and Application of Knowledge Base for Toxic Herbal Materials

LI Xiaoyang¹, WANG Yilin², XU Jing², TONG Lin¹, ZHAI Min³, JIANG Wenbo³, HE Yanxian³, LEI Lei^1#, YOU Yun^2,*

¹Institute of Information on Traditional Chinese Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China;
²Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China;
³BeiDou Satellite Global Navigation Co., LTD, Beijing 100160, China

Received:2024-09-11 Online:2024-12-15 Published:2024-12-16

摘要/Abstract

摘要： 目的探讨建立毒性药材知识库,为安全使用中药材提供参考。方法研究采用知识图谱存储结构结合可视化技术组织毒性药材的毒性靶器官、毒性剂量等信息,搭建毒性药材可视化平台。结果研究构建的毒性药材专题知识库对毒性药材、含有毒性药材的中成药和毒性成分的毒性实验报道分别进行系统汇总,实现毒性药材知识整合和数据关联性的提高。结论本平台将为有毒中药的应用研究、发展和传承提供数据服务支撑。

关键词: 毒性药材, 知识库构建, 知识图谱, 药品不良反应, 毒性剂量

Abstract: Objective To establish a knowledge base of toxic traditional Chinese medicine. Methods A knowledge graph storage structure combined with visualization technology was adopted to present the information about the toxin-targeted organs and toxic doses. A visualization platform was built for toxic medicinal materials. Results The knowledge base exclusively related to toxic traditional Chinese medicine constructed by the study summarized the reports about toxic experiments on toxic traditional Chinese medicine, traditional Chinese patent medicines and simple preparations containing toxic traditional Chinese medicine and toxic ingredients, integrated the knowledge of toxic traditional Chinese medicine and kept data more correlated. Conclusion This platform will provide data service support for the applicational research, development, and inheritance of toxic traditional Chinese medicine.

Key words: Toxic Traditional Chinese Medicine, Knowledge Base Construction, Knowledge Graph, Adverse Drug Reaction, Toxic Dose

中图分类号:

R917

李小阳, 王贻琳, 许静, 佟琳, 翟敏, 蒋文博, 何燕贤, 雷蕾, 游云. 毒性药材专题知识库构建及应用[J]. 中国药物警戒, 2024, 21(12): 1415-1418.

LI Xiaoyang, WANG Yilin, XU Jing, TONG Lin, ZHAI Min, JIANG Wenbo, HE Yanxian, LEI Lei, YOU Yun. Construction and Application of Knowledge Base for Toxic Herbal Materials[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1415-1418.

导出引用管理器 EndNote|Ris|BibTeX

链接本文: https://zgywjj.magtechjournal.com/CN/10.19803/j.1672-8629.20240705

https://zgywjj.magtechjournal.com/CN/Y2024/V21/I12/1415

参考文献

[1] National Pharmacopoeia Commission.Pharmacopoeia of the People's Republic of China. Volume Ⅰ (中华人民共和国药典一部 ) [M]. Beijing: China Medical Science Press, 2020.
[2] XU L, YAN DM, NIE HY, et al.Reflection and Exploration on the Toxicity Grading Standards of Traditional Chinese Medicine Based on the Current Status of Toxic Medicinal Materials Standards in the 2020 Edition of the Chinese Pharmacopoeia[J]. Journal of Chinese Medicinal Materials(中药材), 2021, 44(5): 1041-1045.
[3] HOOFNAGLE JH, SERRANO J, KNOBEN JE, et al.LiverTox: A Website on Drug-Induced Liver Injury[J]. Hepatology, 2013, 57(3): 873-874.
[4] DAVIS AP, WIEGERS TC, JOHNSON RJ, et al.Comparative Toxicogenomics Database(CTD): Update 2023[J]. Nucleic Acids Res, 2023, 51(D1): D1257-D1262.
[5] KUHN M, LETUNIC I, JENSEN LJ, et al.The SIDER Database of Drugs and Side Effects[J]. Nucleic Acids Res, 2016, 44(D1): D1075-D1079.
[6] National Pharmacopoeia Commission. Chinese Materia Medica(中华本草)[M]. Shanghai: Shanghai Scientific & Technical Publishers,1999.
[7] ZHAO H, YANG Y, WANG SQ, et al.NPASS Database Update 2023: Quantitative Natural Product Activity and Species Source Database for Biomedical Research[J]. Nucleic Acids Res, 2023, 51(D1): D621-D628.
[8] WANG X, LI HY, KANG L, et al.Construction and Application of TCM Miner[J]. Chinese Journal of Library and Information Science for Traditional Chinese Medicine(中国中医药图书情报杂志), 2021, 45(4): 1-6.
[9] YOU Y, HUANG FH, HAN L.Advances in Reproduction Toxicity Study on Traditional Chinese Materia Medica Recorded in Chinese Pharmacopoeia as Prohibited or Used with Caution During Pregnancy[J]. Chinese Journal of Pharmacology and Toxicology(中国药理学与毒理学杂志), 2018, 32(5): 364-370.
[10] CHEN RS.Reflection and Evolution of Materia Medica from the Perspective of Understanding and Handling the Toxicity of Chinese Drugs[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2024, 30(1): 104-107.
[11] CHEN RS, ZHOU YQ.Analysis of Relativity and Variability of Chinese Herbalism Toxicity[J]. Journal of Basic Chinese Medicine(中国中医基础医学杂志), 2012, 18(11): 1257-1259.
[12] YANG YL, WANG YL, GUI XJ.Retrospective Analysis of Rational Use of Aristolochia Manshuriensis[J]. Chinese Journal of Modern Applied Pharmacy(中国现代应用药学), 2020, 37(23): 2925-2931.
[13] XIAN Z.Study on the Toxicity Difference and Mechanism of Representative Aristolochic Acids (AA-I, AA-IVa) in Commonly Used Aristolochiaceae Plants[D]. Beijing: China Academy of Chinese Medical Sciences, 2022.
[14] ZHAO CJ, JIA Z, TANG Y, et al.Exploring the Toxicity Characteristics of Traditional Chinese Medicine Based on The “Toxicity-Effect” Relationship[J]. Global Traditional Chinese Medicine(环球中医药), 2024, 17(8): 1602-1606.
[15] PAN XQ, PENG C.Research Methods and Thoughts on the Integrated Study of the Complex Interaction Network Between “Toxicity and Efficacy” Induced by The Toxic Chinese Materia Medica[J]. China Journal of Traditional Chinese Medicine and Pharmacy(中华中医药杂志), 2023, 38(4): 1421-1425.
[16] HE YH, LI M, LUO XL, et al.Research on Entity and Relation Extraction from Traditional Chinese Medicine Knowledge Graphs Based on GPTs[J]. Shanghai Journal of Traditional Chinese Medicine(上海中医药杂志), 2024, 58(8): 1-6.

毒性药材专题知识库构建及应用

Construction and Application of Knowledge Base for Toxic Herbal Materials

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	孟康康, 夏玉坤. 昂丹司琼制剂安全性风险分析[J]. 中国药物警戒, 2024, 21(9): 1034-1038.
[2]	吴凡, 付林杰, 祝赫, 徐梦艳. 基于美国FAERS和日本JADER数据库的内皮素受体拮抗剂不良事件信号分析[J]. 中国药物警戒, 2024, 21(9): 1056-1063.
[3]	卢靖, 喻珊珊, 童菲, 林卓慧, 宋路瑶. 达格列净片致严重便秘1例分析[J]. 中国药物警戒, 2024, 21(9): 1071-1074.
[4]	刘婷, 曹忠强, 何文佳, 袁秀丽, 陈泽彬, 李学娟. 培门冬酶注射液致急性重症胰腺炎1例分析[J]. 中国药物警戒, 2024, 21(9): 1075-1077.
[5]	魏芬芳, 吴文宇, 李丽敏, 唐碧雨, 吴建茹. 国外药品获益-风险评价方法概述与启示[J]. 中国药物警戒, 2024, 21(8): 900-905.
[6]	王玉玺, 张宗林, 王颖丽, 陈亚飞, 李俊生, 霍艳飞, 谢彦军, 刘文启. 560例脉络舒通丸不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 921-924.
[7]	赵俊, 董丽, 王洋, 梁瑜, 杨雪, 李恩泽. 艾司洛尔不良反应/事件报告分析[J]. 中国药物警戒, 2024, 21(8): 925-930.
[8]	张乾, 恽渊, 何恋. 1例利培酮致高泌乳素血症患者的药学监护[J]. 中国药物警戒, 2024, 21(8): 936-938.
[9]	晁滢, 张学梅, 张成健, 王贝. 注射用头孢曲松钠致儿童输尿管结石及胆囊结石1例分析[J]. 中国药物警戒, 2024, 21(8): 943-945.
[10]	郭海嬿, 何波, 闫鸿丽, 杨雪婷. 稳心颗粒致持续性呃逆1例分析[J]. 中国药物警戒, 2024, 21(8): 946-948.
[11]	王丹, 董铎, 田春华. 我国药物警戒制度发展历程和思考[J]. 中国药物警戒, 2024, 21(7): 735-740.
[12]	邵波, 郭晓昕. 中药药物警戒回顾与思考[J]. 中国药物警戒, 2024, 21(7): 741-745.
[13]	阿拉腾花, 王振兴, 张晓朦, 世伟, 席成伟, 王聪慧, 王立群, 张冰. 基于药品不良反应监测数据的心脏器官伤害风险信号挖掘分析[J]. 中国药物警戒, 2024, 21(7): 752-758.
[14]	程毅菁, 李涛, 刘军廷, 黄贵民, 钟旭丽, 林爱华, 潘守东, 李龙, 白东升, 占小俊, 刘振江, 任韡, 聂晓璐, 邰隽. 基于真实世界数据的注射用尖吻蝮蛇血凝酶儿童用药安全性评价[J]. 中国药物警戒, 2024, 21(7): 787-790.
[15]	赵杰, 高明娥, 常虹, 范惠霞. 复方聚乙二醇电解质散致患儿过敏样反应2例分析[J]. 中国药物警戒, 2024, 21(7): 816-818.